Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × NSCLC × Cryotherapy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Warts 11 Breast Neoplasms 10 Prostatic Neoplasms 9 Keratosis, Actinic 9 Retinoblastoma 7 Uterine Cervical Dysplasia 6 Peripheral Nervous System Diseases 6 Stomatitis 4 Neoplasms 4 Uterine Cervical Neoplasms 3 Mucositis 3 Lung Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Stomach Neoplasms 2 Papillomavirus Infections 2 Pancreatic Neoplasms 2 Pain 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Melanoma 2 Keratosis 2 Deglutition Disorders 2 Carcinoma, Ductal, Breast 2 Carcinoma, Basal Cell 2 Wilms Tumor 1 Ulcer 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1

Interventions

Pemetrexed 9 Drug Therapy 9 osimertinib 7 Radiotherapy 6 Carboplatin 6 anlotinib 5 Radiosurgery 5 Gefitinib 4 Docetaxel 4 Cisplatin 4 tislelizumab 3 pembrolizumab 3 icotinib 3 aflutinib 3 Vinorelbine 3 Paclitaxel 3 Gemcitabine 3 Erlotinib Hydrochloride 3 toripalimab 2 dacomitinib 2 camrelizumab 2 apatinib 2 Tyrosine Kinase Inhibitors 2 Thalidomide 2 Surgical Procedures, Operative 2 S 1 (combination) 2 Platinum 2 Liquid Biopsy 2 Immune Checkpoint Inhibitors 2 Chemotherapy, Adjuvant 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07530744 2026-04-15

Cronos

Elisabethinen Hospital

Phase NA Not yet recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡